News
1 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Gandhinagar, India 2 School of Pharmacy, Queen’s University Belfast, Belfast, United ...
Coherus Oncology, Inc. (Coherus Oncology, Nasdaq: CHRS), a commercial-stage innovative oncology company, formerly named Coherus BioSciences Inc.
Immunotherapy company BioNTech SE (BNTX) and Bristol Myers Squibb (BMY) announced Monday they have entered into an agreement for the global co-development and co-commercialization ...
Triple-negative breast cancer (TNBC) - closeup view 3d illustration] Nemes Laszlo/iStock via Gilead Sciences (NASDAQ:GILD [ announced Saturday that its antibody-drug conjugate Trodelvy, in ...
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces a proposed consolidation of the ...
Ernexa Therapeutics announced that data on its novel immunotherapy platform using induced mesenchymal stem cells (iMSCs) will be presented at the ASCO Annual Meeting 2025 on June 2 in Chicago.
But the word "pride" was not always associated with colorful and lively festivities. Nor was it always a symbol for LGBTQ empowerment and strength. The first known use of the word "pride" dates back ...
Instil Bio (NASDAQ:TIL) stock surges on updates from its clinical programs for bispecific antibody IMM2510/AXN-2510 targeted at solid tumors. Read more here.
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. But woven throughout ...
VATICAN CITY (AP) — Pope Leo XIV, history’s first American pope, vowed Sunday to work for unity so that the Catholic Church becomes a symbol of peace in the world, offering a message of ...
VATICAN CITY (AP) — Pope Leo XIV, history’s first American pope, vowed Sunday to work for unity so that the Catholic Church becomes a symbol of peace in the world, offering a message of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results